Trial intelligence / Profile preview

Amiloride in CKD with Proteinuria

NCT06923709Phase 2Recruiting

Sponsor
University Hospital Odense
Start
Oct 2024
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of amiloride in chronic kidney disease (CKD), sponsored by University Hospital Odense. Started Oct 2024; status: recruiting.

02

Drugs

amiloride
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT06923709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06923709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call